Senior insider sale
Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$4.12M
39.39K shares
What this filing means
SHULMAN JOSEPH plans to sell 39.39K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $4.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/16/2025ACC: 0001950047-25-008024
Officer· Chief Technical Officer
Since Feb 2022
39.39K
Shares to sell
$4.12M
Approx. market value
14.44K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
10/16/2025
14.44KTotal acquired14.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/16/2025 | Exercise of Stock Options Cash | 14.44K | — |
| Total | 14.44K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
16.78K
Market value
$1.77M
9/2/2025
—Completed
Units to sell
4.19K
Market value
$419.1K
8/21/2025
—Completed
Units to sell
3.98K
Market value
$358.9K
8/11/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.44K
Market value
$1.58M
10/16/2025
Total
Units
39.39K
Value
$4.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2025 | 16.78K | $1.77M | — | Completed |
8/21/2025 | 4.19K | $419.1K | — | Completed |
8/11/2025 | 3.98K | $358.9K | — | Completed |
| Planned — Approximate Date | ||||
10/16/2025 | 14.44K | $1.58M | NASDAQ | Planned |
| Total | 39.39K | $4.12M | ||